ICIsrenal cell carcinomamelanomanon-small cell lung cancerNSIGCcancerUniversity of Oklahoma
… 19 institutions worldwide on patients with cancer who received ICIs (alone or in combination with other drugs) between 2015-2025 an…
45articles mentioning drugs
52drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ICIs ×
ICIs
This drug is selected. Its supporting articles are shown below.
Articles mentioning ICIs
45 articles · page 3 of 4ICIsImmune checkpoint inhibitorsstage III melanomaJAMA OncolJAMA Network Open
…Background Immune checkpoint inhibitors (ICIs) have transformed the management of stage III melanoma, offerin…
ICIsECOG Performance StatusRenal Cell CarcinomaMelanomaBladder Cancerurothelial cancersAmerican University of BeirutRCCChemotherapyAUB
…Background Immune checkpoint inhibitors (ICIs) have revolutionized the management of many malignancies, inclu…
79.0%
ICIspancreatitispancreatic malignancymelanoma
…Background Immune checkpoint inhibitors (ICIs) have transformed cancer therapy by enhancing antitumor immunit…
immune checkpoint inhibitorsICIsnon-small cell lung cancerneoadjuvant chemotherapyTianjin Medical University Cancer Institute and HospitalNSCLC
…SCLC) patients receiving neoadjuvant chemotherapy combined with immune checkpoint inhibitors (ICIs).Methods Cases meeting inclusion criteria were divided in…
ICIsimmune checkpoint inhibitorsGBMglioblastomasolid tumorsimmunotherapy
…Background Although immune checkpoint inhibitors (ICIs) have demonstrated success in several solid tumors, response am…
ICIsintracerebroventricular GL261 gliomasCT26-hHER2 modelID8 tumors
…Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, with efficacy closely link…
77.1%
ICIsmelanomaNSCLChead and neck squamous cell carcinomatriple-negative breast cancernon-small cell lung cancerYale UniversityHNSCCYale Human Investigation CommitteeTNBC
…Background Immune checkpoint inhibitors (ICIs) have shown clinical efficacy across multiple tumor types, incl…
78.0%
guadecitabineaCD40aGD2entinostatICIs
…pigenetic inhibitors (EMis). We identified inhibitors of DNMTs (guadecitabine, ‘Guad’) and HDACs (entinostat, ‘Ent’) that, when combined with…
ICIsImmune checkpoint inhibitorsTriple-negative breast cancerNCT03366844radiation therapyTNBC
…prising 10-15% of breast cancers. Immune checkpoint inhibitors (ICIs), especially when combined with radiation therapy (RT), have sh…
Immune checkpoint inhibitorsICIsUniversity of Michiganmelanomamicrosatellite instability-high (MSI-H) tumorsfirst-line immunotherapy
…Background Immune checkpoint inhibitors (ICIs) continue to have an increasing role in oncology, offerin…
ICIsadvanced head and neck squamous cell carcinoma (HNSCC)Radiation therapyTCGAThe Cancer Genome Atlas
… immune responses. Unfortunately, immune checkpoint inhibitors (ICIs) have poor or no efficacy for the majority of advanced HNSCC pa…